Symbols / VCYT Stock $33.00 -2.11% Veracyte, Inc.
VCYT (Stock) Chart
About
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Stock Fundamentals
Scroll to Statements| Market Cap | 2.62B | Enterprise Value | 2.31B | Income | 66.35M | Sales | 517.14M | Book/sh | 16.50 | Cash/sh | 5.20 |
| Dividend Yield | — | Payout | 0.00% | Employees | 755 | IPO | — | P/E | 40.24 | Forward P/E | 18.72 |
| PEG | — | P/S | 5.07 | P/B | 2.00 | P/C | — | EV/EBITDA | 27.31 | EV/Sales | 4.46 |
| Quick Ratio | 7.63 | Current Ratio | 8.15 | Debt/Eq | 3.03 | LT Debt/Eq | — | EPS (ttm) | 0.82 | EPS next Y | 1.76 |
| EPS Growth | 7.12% | Revenue Growth | 18.50% | Earnings | 2026-05-05 | ROA | 2.91% | ROE | 5.34% | ROIC | — |
| Gross Margin | 72.17% | Oper. Margin | 17.50% | Profit Margin | 12.83% | Shs Outstand | 79.46M | Shs Float | 79.02M | Short Float | 8.87% |
| Short Ratio | 5.89 | Short Interest | — | 52W High | 50.71 | 52W Low | 22.61 | Beta | 1.96 | Avg Volume | 905.72K |
| Volume | 159.92K | Target Price | $46.55 | Recom | Buy | Prev Close | $33.71 | Price | $33.00 | Change | -2.11% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-20 | main | Canaccord Genuity | Hold → Hold | $40 |
| 2026-04-13 | init | Jefferies | — → Buy | $45 |
| 2026-04-01 | main | Needham | Buy → Buy | $48 |
| 2026-03-30 | main | Guggenheim | Buy → Buy | $45 |
| 2026-03-06 | main | Morgan Stanley | Underweight → Underweight | $37 |
| 2026-02-26 | main | Needham | Buy → Buy | $48 |
| 2026-01-05 | main | Guggenheim | Buy → Buy | $50 |
| 2025-12-02 | main | Morgan Stanley | Underweight → Underweight | $48 |
| 2025-11-11 | main | Morgan Stanley | Underweight → Underweight | $40 |
| 2025-11-05 | main | UBS | Buy → Buy | $48 |
| 2025-11-05 | main | Canaccord Genuity | Hold → Hold | $43 |
| 2025-11-05 | main | Guggenheim | Buy → Buy | $45 |
| 2025-11-05 | main | Needham | Buy → Buy | $44 |
| 2025-10-20 | init | Canaccord Genuity | — → Hold | $40 |
| 2025-10-17 | init | Freedom Capital Markets | — → Buy | $45 |
| 2025-05-08 | main | UBS | Buy → Buy | $42 |
| 2025-05-08 | main | Needham | Buy → Buy | $41 |
| 2025-04-09 | main | Guggenheim | Buy → Buy | $37 |
| 2025-03-26 | reit | Stephens & Co. | Overweight → Overweight | $45 |
| 2025-03-20 | init | Craig-Hallum | — → Buy | $45 |
- VCYT Veracyte delivers triple digit Q4 2025 EPS beat and 16 percent annual revenue growth despite mild stock dip. - Spin Off - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 04
- Veracyte (NASDAQ: VCYT) asks investors to back directors, auditor and larger equity plan - Stock Titan Wed, 22 Apr 2026 20
- Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance Fri, 27 Mar 2026 07
- VCYT Maintained by Canaccord Genuity -- Price Target Lowered to $40 - GuruFocus Mon, 20 Apr 2026 20
- Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 33% Potential Upside in Diagnostics Innovation - DirectorsTalk Interviews ue, 24 Feb 2026 08
- VCYT Stock Analysis: Veracyte Inc. trades near 32.4 dollar mark with slight daily gains - Cổng thông tin điện tử Tỉnh Sơn La Wed, 01 Apr 2026 07
- Veracyte Inc. (NASDAQ:VCYT) Emerges as a Prime Affordable Growth Candidate - ChartMill Mon, 26 Jan 2026 08
- Veracyte, Inc. (NASDAQ:VCYT) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st Sat, 22 Nov 2025 08
- Veracyte sets May 5 earnings call and business update for 4:30 p.m. ET - Stock Titan ue, 14 Apr 2026 20
- Is Veracyte (VCYT) Pricing Reflect Future Cash Flows After Multi Year Share Price Slide - Yahoo Finance ue, 10 Feb 2026 08
- Assessing Veracyte (VCYT) Valuation After A Recent Share Price Rebound - simplywall.st Wed, 15 Apr 2026 10
- Veracyte (NASDAQ: VCYT) awards 44,221 RSUs to Chief Dev and Tech Officer - Stock Titan ue, 14 Apr 2026 07
- Does Veracyte (VCYT) Offer Both Strength and Opportunity? - Yahoo Finance Mon, 23 Feb 2026 08
- More cancer patients get lab answers as Veracyte test use jumps 19% - Stock Titan Sun, 11 Jan 2026 08
- Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings - Yahoo Finance Mon, 16 Feb 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
517.14
+16.01%
|
445.76
+23.46%
|
361.05
+21.76%
|
296.54
|
| Operating Revenue |
|
517.14
+16.01%
|
445.76
+23.46%
|
361.05
+21.76%
|
296.54
|
| Cost Of Revenue |
|
154.61
+4.74%
|
147.62
+12.37%
|
131.37
+8.70%
|
120.86
|
| Reconciled Cost Of Revenue |
|
135.69
+6.46%
|
127.46
+19.92%
|
106.28
+9.56%
|
97.01
|
| Gross Profit |
|
362.53
+21.60%
|
298.14
+29.81%
|
229.68
+30.74%
|
175.68
|
| Operating Expense |
|
284.25
+2.02%
|
278.63
+12.75%
|
247.13
+17.11%
|
211.02
|
| Research And Development |
|
70.81
+2.19%
|
69.29
+20.92%
|
57.30
+41.13%
|
40.60
|
| Selling General And Administration |
|
210.95
+2.38%
|
206.04
+9.76%
|
187.72
+9.93%
|
170.76
|
| Selling And Marketing Expense |
|
30.96
+11.46%
|
27.77
+4.39%
|
26.60
+5.15%
|
25.30
|
| General And Administrative Expense |
|
179.99
+0.97%
|
178.27
+10.65%
|
161.12
+10.76%
|
145.46
|
| Salaries And Wages |
|
152.12
+6.77%
|
142.48
+2.76%
|
138.66
+12.17%
|
123.61
|
| Other Gand A |
|
27.88
-22.13%
|
35.80
+59.37%
|
22.46
+2.82%
|
21.84
|
| Total Expenses |
|
438.86
+2.96%
|
426.25
+12.62%
|
378.50
+14.05%
|
331.88
|
| Operating Income |
|
78.28
+301.24%
|
19.51
+211.83%
|
-17.45
+50.63%
|
-35.34
|
| Total Operating Income As Reported |
|
57.78
+257.93%
|
16.14
+118.81%
|
-85.80
-108.84%
|
-41.08
|
| EBITDA |
|
89.62
+82.13%
|
49.20
+199.59%
|
-49.41
-379.65%
|
-10.30
|
| Normalized EBITDA |
|
112.86
+106.63%
|
54.62
+199.82%
|
18.22
+353.72%
|
-7.18
|
| Reconciled Depreciation |
|
21.41
-8.71%
|
23.46
-13.72%
|
27.19
+4.86%
|
25.93
|
| EBIT |
|
68.20
+164.90%
|
25.75
+133.61%
|
-76.60
-111.42%
|
-36.23
|
| Total Unusual Items |
|
-23.24
-329.34%
|
-5.41
+92.00%
|
-67.63
-2066.81%
|
-3.12
|
| Total Unusual Items Excluding Goodwill |
|
-23.24
-329.34%
|
-5.41
+92.00%
|
-67.63
-2066.81%
|
-3.12
|
| Special Income Charges |
|
-27.21
-707.99%
|
-3.37
+95.07%
|
-68.35
-1959.95%
|
-3.32
|
| Impairment Of Capital Assets |
|
—
|
3.37
-95.07%
|
68.35
+1959.95%
|
3.32
|
| Write Off |
|
20.50
+508.82%
|
3.37
-95.07%
|
68.35
+1959.95%
|
3.32
|
| Net Income |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Pretax Income |
|
68.20
+164.92%
|
25.74
+133.60%
|
-76.61
-110.32%
|
-36.43
|
| Net Non Operating Interest Income Expense |
|
12.72
+14.09%
|
11.15
+52.16%
|
7.33
+313.13%
|
1.77
|
| Interest Expense Non Operating |
|
0.00
-50.00%
|
0.00
-86.67%
|
0.01
-92.42%
|
0.20
|
| Net Interest Income |
|
12.72
+14.09%
|
11.15
+52.16%
|
7.33
+313.13%
|
1.77
|
| Interest Expense |
|
0.00
-50.00%
|
0.00
-86.67%
|
0.01
-92.42%
|
0.20
|
| Interest Income Non Operating |
|
12.72
+14.08%
|
11.15
+51.88%
|
7.34
+272.41%
|
1.97
|
| Interest Income |
|
12.72
+14.08%
|
11.15
+51.88%
|
7.34
+272.41%
|
1.97
|
| Other Income Expense |
|
-22.80
-363.68%
|
-4.92
+92.60%
|
-66.50
-2224.19%
|
-2.86
|
| Other Non Operating Income Expenses |
|
0.44
-11.92%
|
0.49
-56.23%
|
1.13
+335.00%
|
0.26
|
| Gain On Sale Of Security |
|
3.97
+294.28%
|
-2.04
-382.85%
|
0.72
+267.01%
|
0.20
|
| Gain On Sale Of Business |
|
-6.71
|
—
|
—
|
—
|
| Tax Provision |
|
1.85
+15.07%
|
1.61
+172.74%
|
-2.21
-1760.15%
|
0.13
|
| Tax Rate For Calcs |
|
0.00
-56.72%
|
0.00
+116.45%
|
0.00
-86.28%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.63
-85.82%
|
-0.34
+82.67%
|
-1.95
-197.37%
|
-0.66
|
| Net Income Including Noncontrolling Interests |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Net Income From Continuing Operation Net Minority Interest |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Net Income From Continuing And Discontinued Operation |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Net Income Continuous Operations |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Normalized Income |
|
88.97
+204.54%
|
29.21
+434.75%
|
-8.73
+74.40%
|
-34.09
|
| Net Income Common Stockholders |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Diluted EPS |
|
0.82
+164.52%
|
0.31
+130.39%
|
-1.02
-100.00%
|
-0.51
|
| Basic EPS |
|
0.84
+162.50%
|
0.32
+131.37%
|
-1.02
-100.00%
|
-0.51
|
| Basic Average Shares |
|
78.58
+2.75%
|
76.48
+5.29%
|
72.64
+1.53%
|
71.55
|
| Diluted Average Shares |
|
80.57
+3.08%
|
78.16
+7.60%
|
72.64
+1.53%
|
71.55
|
| Diluted NI Availto Com Stockholders |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Amortization |
|
2.49
-24.57%
|
3.30
+56.55%
|
2.11
+1.20%
|
2.08
|
| Amortization Of Intangibles Income Statement |
|
2.49
-24.57%
|
3.30
+56.55%
|
2.11
+1.20%
|
2.08
|
| Depreciation Amortization Depletion Income Statement |
|
2.49
-24.57%
|
3.30
+56.55%
|
2.11
+1.20%
|
2.08
|
| Depreciation And Amortization In Income Statement |
|
2.49
-24.57%
|
3.30
+56.55%
|
2.11
+1.20%
|
2.08
|
| Depreciation Income Statement |
|
—
|
—
|
3.49
+55.32%
|
2.25
|
| Other Taxes |
|
—
|
-0.50
+13.13%
|
-0.57
+76.43%
|
-2.42
|
| Rent And Landing Fees |
|
—
|
—
|
8.11
+39.48%
|
5.82
|
| Rent Expense Supplemental |
|
—
|
—
|
8.11
+39.48%
|
5.82
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1,406.02
+8.15%
|
1,300.04
+16.60%
|
1,114.91
-3.59%
|
1,156.42
|
| Current Assets |
|
488.38
+31.19%
|
372.27
+30.34%
|
285.62
+14.88%
|
248.64
|
| Cash Cash Equivalents And Short Term Investments |
|
412.89
+42.65%
|
289.44
+33.72%
|
216.45
+21.02%
|
178.85
|
| Cash And Cash Equivalents |
|
362.58
+51.65%
|
239.09
+10.46%
|
216.45
+40.33%
|
154.25
|
| Other Short Term Investments |
|
50.31
-0.09%
|
50.35
|
0.00
-100.00%
|
24.61
|
| Receivables |
|
44.66
-4.01%
|
46.52
+15.22%
|
40.38
-8.28%
|
44.02
|
| Accounts Receivable |
|
44.66
-4.01%
|
46.52
+15.22%
|
40.38
-8.28%
|
44.02
|
| Inventory |
|
20.55
-5.54%
|
21.75
+34.86%
|
16.13
+12.83%
|
14.29
|
| Raw Materials |
|
20.55
+14.94%
|
17.88
+10.84%
|
16.13
+12.83%
|
14.29
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
10.28
-29.35%
|
14.55
+14.93%
|
12.66
+10.39%
|
11.47
|
| Total Non Current Assets |
|
917.64
-1.09%
|
927.77
+11.88%
|
829.28
-8.65%
|
907.79
|
| Net PPE |
|
58.79
-17.36%
|
71.14
+130.52%
|
30.86
0.00%
|
30.86
|
| Gross PPE |
|
102.27
-7.47%
|
110.53
+73.46%
|
63.72
+12.10%
|
56.84
|
| Accumulated Depreciation |
|
-43.48
-10.39%
|
-39.39
-19.87%
|
-32.86
-26.47%
|
-25.98
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
16.58
-7.29%
|
17.88
+29.05%
|
13.86
+13.60%
|
12.20
|
| Construction In Progress |
|
0.00
-100.00%
|
0.11
-95.70%
|
2.46
+319.93%
|
0.59
|
| Other Properties |
|
73.32
-10.50%
|
81.92
+120.84%
|
37.09
+8.08%
|
34.32
|
| Leases |
|
12.38
+16.49%
|
10.62
+3.10%
|
10.31
+5.81%
|
9.74
|
| Goodwill And Other Intangible Assets |
|
856.30
+0.97%
|
848.10
+7.14%
|
791.58
-9.09%
|
870.76
|
| Goodwill |
|
767.15
+2.86%
|
745.80
+6.09%
|
702.98
+1.02%
|
695.89
|
| Other Intangible Assets |
|
89.15
-12.86%
|
102.30
+15.47%
|
88.59
-49.34%
|
174.87
|
| Other Non Current Assets |
|
2.55
-70.09%
|
8.53
+24.51%
|
6.85
+11.03%
|
6.17
|
| Total Liabilities Net Minority Interest |
|
96.44
-22.27%
|
124.07
+75.23%
|
70.80
-12.83%
|
81.22
|
| Current Liabilities |
|
59.94
-23.78%
|
78.63
+28.40%
|
61.24
-2.19%
|
62.61
|
| Payables And Accrued Expenses |
|
25.93
+18.61%
|
21.86
-12.33%
|
24.94
+30.93%
|
19.05
|
| Payables |
|
4.59
-46.80%
|
8.63
-33.29%
|
12.94
+8.66%
|
11.91
|
| Accounts Payable |
|
4.59
-46.80%
|
8.63
-33.29%
|
12.94
+8.66%
|
11.91
|
| Current Accrued Expenses |
|
21.34
+61.30%
|
13.23
+10.29%
|
12.00
+68.10%
|
7.14
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
27.46
-10.25%
|
30.59
+15.76%
|
26.43
-13.73%
|
30.64
|
| Current Debt And Capital Lease Obligation |
|
4.05
-45.99%
|
7.50
+46.91%
|
5.11
+25.43%
|
4.07
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
4.05
-45.99%
|
7.50
+46.91%
|
5.11
+25.43%
|
4.07
|
| Current Deferred Liabilities |
|
1.16
-30.66%
|
1.67
-16.68%
|
2.01
-23.15%
|
2.61
|
| Current Deferred Revenue |
|
1.16
-30.66%
|
1.67
-16.68%
|
2.01
-23.15%
|
2.61
|
| Other Current Liabilities |
|
1.33
-92.16%
|
17.00
+516.39%
|
2.76
-55.84%
|
6.25
|
| Total Non Current Liabilities Net Minority Interest |
|
36.51
-19.65%
|
45.44
+375.12%
|
9.56
-48.61%
|
18.61
|
| Long Term Debt And Capital Lease Obligation |
|
35.60
-17.66%
|
43.24
+474.58%
|
7.53
-29.33%
|
10.65
|
| Long Term Capital Lease Obligation |
|
35.60
-17.66%
|
43.24
+474.58%
|
7.53
-29.33%
|
10.65
|
| Non Current Deferred Liabilities |
|
0.65
-47.35%
|
1.23
+67.17%
|
0.73
-83.80%
|
4.53
|
| Non Current Deferred Revenue |
|
—
|
—
|
—
|
0.00
|
| Non Current Deferred Taxes Liabilities |
|
0.65
-47.35%
|
1.23
+67.17%
|
0.73
-83.80%
|
4.53
|
| Other Non Current Liabilities |
|
0.26
-73.56%
|
0.97
-25.46%
|
1.30
-61.97%
|
3.43
|
| Stockholders Equity |
|
1,309.58
+11.36%
|
1,175.97
+12.63%
|
1,044.10
-2.89%
|
1,075.20
|
| Common Stock Equity |
|
1,309.58
+11.36%
|
1,175.97
+12.63%
|
1,044.10
-2.89%
|
1,075.20
|
| Capital Stock |
|
0.08
+1.28%
|
0.08
+6.85%
|
0.07
+1.39%
|
0.07
|
| Common Stock |
|
0.08
+1.28%
|
0.08
+6.85%
|
0.07
+1.39%
|
0.07
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
79.36
+2.04%
|
77.77
+6.15%
|
73.26
+1.81%
|
71.96
|
| Ordinary Shares Number |
|
79.36
+2.04%
|
77.77
+6.15%
|
73.26
+1.81%
|
71.96
|
| Additional Paid In Capital |
|
1,695.34
+2.38%
|
1,655.96
+7.80%
|
1,536.17
+2.40%
|
1,500.19
|
| Retained Earnings |
|
-377.63
+14.94%
|
-443.98
+5.16%
|
-468.12
-18.90%
|
-393.72
|
| Gains Losses Not Affecting Retained Earnings |
|
-8.21
+77.25%
|
-36.09
-50.26%
|
-24.02
+23.38%
|
-31.35
|
| Other Equity Adjustments |
|
-8.21
+77.25%
|
-36.09
-50.26%
|
-24.02
+23.38%
|
-31.35
|
| Total Equity Gross Minority Interest |
|
1,309.58
+11.36%
|
1,175.97
+12.63%
|
1,044.10
-2.89%
|
1,075.20
|
| Total Capitalization |
|
1,309.58
+11.36%
|
1,175.97
+12.63%
|
1,044.10
-2.89%
|
1,075.20
|
| Working Capital |
|
428.44
+45.91%
|
293.63
+30.86%
|
224.38
+20.62%
|
186.02
|
| Invested Capital |
|
1,309.58
+11.36%
|
1,175.97
+12.63%
|
1,044.10
-2.89%
|
1,075.20
|
| Total Debt |
|
39.65
-21.84%
|
50.74
+301.72%
|
12.63
-14.19%
|
14.72
|
| Capital Lease Obligations |
|
39.65
-21.84%
|
50.74
+301.72%
|
12.63
-14.19%
|
14.72
|
| Net Tangible Assets |
|
453.27
+38.25%
|
327.87
+29.83%
|
252.53
+23.52%
|
204.44
|
| Tangible Book Value |
|
453.27
+38.25%
|
327.87
+29.83%
|
252.53
+23.52%
|
204.44
|
| Other Inventories |
|
—
|
3.87
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
136.31
+81.51%
|
75.10
+69.82%
|
44.22
+486.89%
|
7.54
|
| Cash Flow From Continuing Operating Activities |
|
136.31
+81.51%
|
75.10
+69.82%
|
44.22
+486.89%
|
7.54
|
| Net Income From Continuing Operations |
|
66.35
+174.89%
|
24.14
+132.44%
|
-74.40
-103.51%
|
-36.56
|
| Depreciation Amortization Depletion |
|
21.41
-8.71%
|
23.46
-13.72%
|
27.19
+4.86%
|
25.93
|
| Depreciation And Amortization |
|
21.41
-8.71%
|
23.46
-13.72%
|
27.19
+4.86%
|
25.93
|
| Other Non Cash Items |
|
-12.30
-272.76%
|
7.12
+681.39%
|
-1.23
-133.70%
|
3.63
|
| Stock Based Compensation |
|
43.60
+20.28%
|
36.25
+9.38%
|
33.14
+23.97%
|
26.73
|
| Asset Impairment Charge |
|
20.50
+508.82%
|
3.37
-95.07%
|
68.35
+1959.95%
|
3.32
|
| Deferred Tax |
|
-0.58
-149.36%
|
-0.23
+93.93%
|
-3.84
-2986.47%
|
0.13
|
| Deferred Income Tax |
|
-0.58
-149.36%
|
-0.23
+93.93%
|
-3.84
-2986.47%
|
0.13
|
| Operating Gains Losses |
|
2.89
+24.96%
|
2.31
+380.24%
|
-0.82
-213.32%
|
0.73
|
| Net Foreign Currency Exchange Gain Loss |
|
-3.83
-281.71%
|
2.11
+292.52%
|
-1.10
-309.96%
|
0.52
|
| Gain Loss On Sale Of PPE |
|
0.01
-92.57%
|
0.20
-25.46%
|
0.27
+31.55%
|
0.21
|
| Change In Working Capital |
|
-2.30
+89.02%
|
-20.96
-467.39%
|
-3.69
+77.44%
|
-16.38
|
| Change In Receivables |
|
-0.71
+88.95%
|
-6.41
-264.78%
|
3.89
+186.47%
|
-4.50
|
| Changes In Account Receivables |
|
-0.71
+88.95%
|
-6.41
-264.78%
|
3.89
+186.47%
|
-4.50
|
| Change In Inventory |
|
-2.86
+51.27%
|
-5.87
-246.58%
|
-1.69
+43.74%
|
-3.01
|
| Change In Prepaid Assets |
|
-2.05
-58.49%
|
-1.30
-182.97%
|
-0.46
-132.95%
|
1.39
|
| Change In Payables And Accrued Expense |
|
5.28
+790.71%
|
-0.76
+5.68%
|
-0.81
+78.50%
|
-3.77
|
| Change In Accrued Expense |
|
6.32
+78.37%
|
3.54
+623.82%
|
-0.68
+82.76%
|
-3.92
|
| Change In Payable |
|
-1.04
+75.87%
|
-4.30
-3112.69%
|
-0.13
-188.16%
|
0.15
|
| Change In Account Payable |
|
-1.04
+75.87%
|
-4.30
-3112.69%
|
-0.13
-188.16%
|
0.15
|
| Change In Other Current Assets |
|
0.53
+142.96%
|
-1.22
-321.38%
|
-0.29
+90.49%
|
-3.05
|
| Change In Other Current Liabilities |
|
-2.48
+54.13%
|
-5.41
-24.87%
|
-4.33
-25.58%
|
-3.45
|
| Investing Cash Flow |
|
-9.21
+83.64%
|
-56.27
-472.39%
|
15.11
+151.42%
|
-29.39
|
| Cash Flow From Continuing Investing Activities |
|
-9.21
+83.64%
|
-56.27
-472.39%
|
15.11
+151.42%
|
-29.39
|
| Net PPE Purchase And Sale |
|
-9.68
+14.26%
|
-11.29
-13.31%
|
-9.96
-16.52%
|
-8.55
|
| Purchase Of PPE |
|
-9.68
+14.26%
|
-11.29
-13.31%
|
-9.96
-16.52%
|
-8.55
|
| Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Capital Expenditure |
|
-9.68
+14.26%
|
-11.29
-13.31%
|
-9.96
-16.52%
|
-8.55
|
| Net Investment Purchase And Sale |
|
3.31
+106.63%
|
-50.00
-299.42%
|
25.07
+220.32%
|
-20.84
|
| Purchase Of Investment |
|
-150.00
-200.00%
|
-50.00
-153.81%
|
-19.70
+41.23%
|
-33.52
|
| Sale Of Investment |
|
153.31
|
0.00
-100.00%
|
44.77
+253.07%
|
12.68
|
| Net Business Purchase And Sale |
|
-2.85
-156.76%
|
5.01
|
0.00
|
0.00
|
| Purchase Of Business |
|
-2.85
|
0.00
|
0.00
|
0.00
|
| Gain Loss On Sale Of Business |
|
6.71
|
0.00
|
0.00
|
—
|
| Financing Cash Flow |
|
-4.22
-186.09%
|
4.90
+72.86%
|
2.84
-18.80%
|
3.49
|
| Cash Flow From Continuing Financing Activities |
|
-4.22
-186.09%
|
4.90
+72.86%
|
2.84
-18.80%
|
3.49
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
|
0.00
+100.00%
|
-1.28
|
| Repayment Of Debt |
|
—
|
0.00
|
0.00
+100.00%
|
-1.28
|
| Long Term Debt Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-1.28
|
| Net Long Term Debt Issuance |
|
—
|
0.00
|
0.00
+100.00%
|
-1.28
|
| Net Common Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
14.08
-29.57%
|
19.99
+108.74%
|
9.58
+20.60%
|
7.94
|
| Net Other Financing Charges |
|
-18.30
-21.31%
|
-15.09
-123.84%
|
-6.74
-112.85%
|
-3.17
|
| Changes In Cash |
|
122.88
+417.92%
|
23.73
-61.84%
|
62.17
+438.66%
|
-18.36
|
| Effect Of Exchange Rate Changes |
|
0.72
+269.58%
|
-0.42
-360.12%
|
0.16
+127.53%
|
-0.59
|
| Beginning Cash Position |
|
240.63
+10.72%
|
217.33
+40.22%
|
155.00
-10.89%
|
173.95
|
| End Cash Position |
|
364.23
+51.36%
|
240.63
+10.72%
|
217.33
+40.22%
|
155.00
|
| Free Cash Flow |
|
126.63
+98.45%
|
63.81
+86.24%
|
34.26
+3478.80%
|
-1.01
|
| Interest Paid Supplemental Data |
|
—
|
0.00
|
0.00
-100.00%
|
0.01
|
| Income Tax Paid Supplemental Data |
|
—
|
2.24
+31.76%
|
1.70
+197.72%
|
0.57
|
| Amortization Of Securities |
|
-3.27
-823.73%
|
-0.35
+24.36%
|
-0.47
|
—
|
| Common Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.00
|
0.00
|
| Sale Of Business |
|
0.00
-100.00%
|
5.01
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-14 View
- 8-K2026-03-16 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-10 View
- 42026-03-06 View
- 42026-03-06 View
- 42026-03-06 View
- 42026-03-06 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-02 View
- 42026-03-02 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|